CRISTINA M. RONDINONE, PH.D.
Vice President R&D, Head Cardiovascular, Renal and Metabolic Diseases Innovative Medicines (iMED), MedImmune
Dr. Cristina Rondinone received her Ph.D. in Biochemistry from University of Buenos Aires. Her postdoctoral training was at the Laboratory of Cellular and Developmental Biology, NIDDK, NIH, USA as a Visiting Fellow. In 1995, she moved to Sweden where she was first Senior Scientist for the Lundberg Laboratory for Diabetes Research, Department of Internal Medicine, University of Gothenburg and then she was appointed as (Docent) Associate Professor in Molecular Medicine, University of Gothenburg.
From 1998 to 2005, she worked at Abbott Laboratories, where she became first Associate Research Fellow of the Volwiler Society and then Group Leader in the metabolic disease research area. In 2005 she moved to Hoffmann-La Roche as Research Director of Metabolic Diseases and in 2007 became Senior Director and Therapeutic Area Head overseeing drug discovery programs in metabolic and vascular diseases, including target identification, lead optimization and advancement of preclinical candidates into clinical development.
In 2011 she moved to MedImmune, Inc., as Vice President Research and Development and Head Cardiovascular and Metabolic Diseases Center of Excellence, leading the portfolio of biologics in this therapeutic area. In 2012, she became Head of Cardiovascular and Metabolic Innovative Medicines and since 2018 she is leading the Cardiovascular, Renal and Metabolic Innovative Medicines.